Molina Healthcare Inc. logo

Molina Healthcare Inc. (MOH)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
207. 36
-5.14
-2.4188%
$
10.28B Market Cap
22.63 P/E Ratio
- Div Yield
678,000 Volume
20.86 Eps
$ 212.5
Previous Close
Add Transaction
Day Range
205.93 214.3
Year Range
121.06 244.89
Want to track MOH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Molina Healthcare beats quarterly profit estimates on controlled medical costs

Molina Healthcare beats quarterly profit estimates on controlled medical costs

Health insurer Molina Healthcare on Wednesday beat Wall Street estimates for first-quarter adjusted profit, helped ​by favorable medical costs, sending its shares ‌up over 2% in after-hours trading.

Reuters | 5 months ago
Will the New Medicare Rates Boost Finally Lift Molina Healthcare?

Will the New Medicare Rates Boost Finally Lift Molina Healthcare?

Molina Healthcare (NYSE:MOH | MOH Price Prediction) reports first-quarter 2026 results after the market closes today.

247wallst | 5 months ago
Earnings Preview: Molina (MOH) Q1 Earnings Expected to Decline

Earnings Preview: Molina (MOH) Q1 Earnings Expected to Decline

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 6 months ago
Molina Healthcare, Inc. (MOH) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Molina Healthcare, Inc. (MOH) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Molina Healthcare, Inc. (MOH) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Seekingalpha | 7 months ago
Molina Healthcare: Still Not Buying This Sick Puppy

Molina Healthcare: Still Not Buying This Sick Puppy

Molina Healthcare reported a disastrous Q4, with a 94.6% MCR and a net loss, slashing 2026 EPS guidance to $5. MOH's management assumptions on claims inflation (5%) lack credibility given recent underestimates and industry trends; margin control remains unproven. New RFP wins, including a $6bn Florida contract, add $9bn in 2026 premiums but introduce substantial risk of underpricing and adverse selection.

Seekingalpha | 8 months ago
Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge

Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge

Molina Healthcare posts Q4 loss as medical costs surge, even as revenues rise 8% and full-year sales top expectations.

Zacks | 8 months ago
Molina (MOH) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Molina (MOH) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 8 months ago
Molina (MOH) Reports Q4 Loss, Tops Revenue Estimates

Molina (MOH) Reports Q4 Loss, Tops Revenue Estimates

Molina (MOH) came out with a quarterly loss of $2.75 per share versus the Zacks Consensus Estimate of $0.43. This compares to earnings of $5.05 per share a year ago.

Zacks | 8 months ago
Will Rising Costs Hit Molina's Q4 Earnings? Key Insights Here

Will Rising Costs Hit Molina's Q4 Earnings? Key Insights Here

MOH heads into Q4 earnings with EPS seen plunging 92.5% year over year as costs rise, even as revenues and premiums are projected to grow.

Zacks | 8 months ago
MOH, Aeroflow Team Up to Offer Virtual Diabetes Care in South Carolina

MOH, Aeroflow Team Up to Offer Virtual Diabetes Care in South Carolina

Molina Healthcare partners with Aeroflow Health to expand nutrition counseling and diabetes care for the former's Commercial and Medicare members in South Carolina.

Zacks | 10 months ago
Molina Healthcare: Investor's Eye 2026 Repricing, Amid Ongoing Buybacks

Molina Healthcare: Investor's Eye 2026 Repricing, Amid Ongoing Buybacks

Molina Healthcare faces a 2025 margin collapse due to elevated medical costs, but sector-wide premium hikes are expected to restore profitability in 2026. MOH is structurally insulated from Medicare Advantage regulatory risks, with earnings less exposed to CMS audit and coding volatility than larger peers. Shares trade at depressed valuations (NTM EV/EBITDA 6.6x, 2026 FCF yield 11-12%), and management is executing opportunistic buybacks at these levels.

Seekingalpha | 10 months ago
Bear of the Day: Molina Healthcare (MOH)

Bear of the Day: Molina Healthcare (MOH)

The company faces escalating operational and financial pressures that threaten its outlook.

Zacks | 10 months ago
Loading...
Load More